N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

US10829445B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10829445-B2
Application numberUS-201916685534-A
CountryUS
Kind codeB2
Filing dateNov 15, 2019
Priority dateMar 17, 2006
Publication dateNov 10, 2020
Grant dateNov 10, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.

First claim

Opening claim text (preview).

What is claimed: 1. A method of preparing a compound of the formula (III) or a pharmaceutically acceptable salt thereof, wherein R 1 is H; R 2 is H; n is 0; b is an integer from 1 to 4; each R 8 is independently selected from halo, CF 3 , NO 2 , CN, phenyl, (C 1 -C 8 )alkyl, SO 2 NHOH, SO 2 CH 3 , SO 2 phenyl, C(O)O(C 1 -C 4 )alkyl, and C(O)morpholino; and Q 9 , Q 11 , Q 12 , Q 13 and Q 14 are defined such that ring C is furan or thiophene; the method comprising reacting a compound of formula A1 with hydroxylamine hydrochloride, wherein the compound of formula A1 has the structure: and R is furan or thiophene and is substituted with 1 to 4 R 8 . 2. The method of claim 1 , wherein, in the compound of formula (III), each R 8 is independently selected from F, Br, Cl, CF 3 , phenyl, methyl, SO 2 NHOH, and C(O)O(C 1 -C 4 )alkyl. 3. The method of claim 2 , wherein, in the compound of formula (III), R 8 is methyl and ring C is furan. 4. A method of preparing a compound of the formula (III) or a pharmaceutically acceptable salt thereof, wherein: R 1 is H; R 2 is H; n is 0; b is 1; R 8 is Cl, Br, nitro, methyl or cyano; and Q 9 , Q 11 , Q 12 , Q 13 and Q 14 are defined such that ring C is furan or thiophene; the method comprising reacting a compound of formula A1 with hydroxylamine hydrochloride, wherein the compound of formula A1 has the structure: and R is furan or thiophene and is substituted with 1 R 8 . 5. The method of claim 4 , wherein, in the compound of formula (III), R 8 is methyl and ring C is furan. 6. A method of preparing a compound which is: or a pharmaceutically acceptable salt thereof, the method comprising reacting a compound of formula A1 with hydroxylamine hydrochloride, wherein the compound of formula A1 has the structure: and is 3,5-dimethylisoxazole-4-sulfonyl chloride. 7. A method of preparing a compound which is: or a pharmaceutically acceptable salt thereof, the method comprising reacting a compound of formula A1 with hydroxylamine hydrochloride, wherein the compound of formula A1 has the structure: and is 1-methyl-1H-pyrazole-3-sulfonyl chloride. 8. A method of preparing a compound which is or a pharmaceutically acceptable salt thereof, the method comprising reacting a compound of formula A1 with hydroxylamine hydrochloride, wherein the compound of formula A1 has the structure: and is 4-bromothiophene-3-sulfonyl chloride, 3-bromothiophene-2-sulfonyl chloride, 4-bromo-2,5-dichlorothiophene-3-sulfonyl chloride or 4-phenyl-5-(trifluoromethyl)thiophene-3-sulfonyl chloride.

Assignees

Inventors

Classifications

  • with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2 · CPC title

  • with substituted hydrocarbon radicals attached to ring carbon atoms · CPC title

  • C07C311/48Primary

    having nitrogen atoms of sulfonamide groups further bound to another hetero atom · CPC title

  • only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers · CPC title

  • with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10829445B2 cover?
The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physi…
Who is the assignee on this patent?
Cardioxyl Pharmaceuticals Inc, Univ Johns Hopkins
What technology area does this patent fall under?
Primary CPC classification C07C311/48. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).